Redefining pharmaceutical innovation
Tatva Pharma Ltd is a UK-based specialty pharmaceutical R&D company dedicated to transforming proven drug molecules into differentiated, patent-smart injectable formulations. We license these innovations globally through a capital-efficient, AI-driven model, making essential medicines work better for everyone.
The unseen challenges in injectable medicines
Many injectable medicines are pharmacologically effective, yet they often fail operationally, creating significant burdens for patients and healthcare systems. Across oncology, critical care, and CNS, treatments frequently demand long infusions, complex preparations, and lead to dosing peaks and troughs that worsen side effects. This results in avoidable side effects, hospital congestion, higher total cost of care, missed doses, and treatment delays. The problem isn't discovery; it's about better design and usability for real-world application.
Re-engineering delivery, not discovery
At Tatva Pharma, we address these challenges by re-engineering how proven drugs are delivered. We don't invent new molecules; instead, we convert existing drug products into smart injectable formulations. Our focus is on redesigning drug delivery to improve tolerability, enhance stability, simplify administration, and optimise drug release behaviour, transforming established medicines into differentiated, defensible assets for real-world use.
Our unique path to impact
Tatva Pharma stands apart by innovating through formulation, not new molecule discovery, significantly reducing R&D risk by working with clinically validated active pharmaceutical ingredients (APIs). We leverage predictive AI to minimise trial-and-error development, operating as a capital-light, IP-heavy licensing platform. Our strategy anchors intellectual property and regulatory efforts in the UK while scaling globally. This unique approach makes injectables faster to administer, easier to prepare, more tolerable for patients, and more efficient for hospitals, ensuring commercial scalability through strategic licensing.
"Tatva makes essential medicines work better in the real world — not by inventing new molecules, but by redesigning how they are delivered."
Tatva Pharma: Modern, patient-centred innovation